Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on X about a paper she co-authored with colleagues published in Medicina:
“Our New paper on RAS mutations in mCRC is just out in Medicina! KRAS/NRAS, resistance, new G12C inhibitors and more.”
Title: RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches
Authors: Osman Sütcüoğlu, Hasan Çağrı Yıldırım, Elvina Almuradova, Damla Günenç, Şuayib Yalçın.
You can read the Full Article in Medicina.
More posts featuring Elvina Almuradova.